Agenus (AGEN) Other Working Capital Changes (2010 - 2018)
Agenus (AGEN) posted quarterly Other Working Capital Changes of $197000.0 for Q4 2025, up 629.63% year-over-year from $27000.0 in Q4 2024, and down 79.09% quarter-over-quarter from $942000.0 in Q3 2025.
Agenus (AGEN) Other Working Capital Changes (2010 - 2018) Analysis & Trends
Agenus' Other Working Capital Changes history runs 16 years deep, the most recent figure standing at $197000.0 for Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 629.63% year-over-year to $197000.0; the TTM figure through Mar 2026 stood at $223000.0 (up 153.86% YoY), while the FY2025 annual figure was $198000.0, up 890.0% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at $197000.0, down from $942000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $23.6 million in Q1 2015, with the low at -$2.7 million in Q2 2015.
- The 5-year median for Other Working Capital Changes is -$715162.0 (2017), against an average of $306613.0.
- Peak annual rise in Other Working Capital Changes reached 717.72% in 2021, while the deepest fall reached 1608.95% in 2021.
- Agenus' Other Working Capital Changes stood at -$19.1 million in 2021, then soared by 103.26% to $621000.0 in 2022, then tumbled by 31.88% to $423000.0 in 2023, then slumped by 93.62% to $27000.0 in 2024, then soared by 629.63% to $197000.0 in 2025.
- Business Quant data shows AGEN's Other Working Capital Changes at $197000.0 in Q4 2025, $942000.0 in Q3 2025, and -$916000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -472,949.00 |
| Mar 31, 2018 | -472,949.00 |
| Mar 31, 2018 | -472,949.00 |
| Dec 31, 2017 | -715,162.00 |
| Dec 31, 2017 | -715,162.00 |
| Dec 31, 2017 | -715,162.00 |
| Sep 30, 2017 | -888,974.00 |
| Sep 30, 2017 | -888,974.00 |
| Sep 30, 2017 | -888,974.00 |
| Jun 30, 2017 | -465,253.00 |
| Jun 30, 2017 | -465,253.00 |
| Jun 30, 2017 | -465,253.00 |
| Mar 31, 2017 | -652,631.00 |
| Mar 31, 2017 | -652,631.00 |
| Mar 31, 2017 | -652,631.00 |
| Dec 31, 2016 | -652,632.00 |
| Dec 31, 2016 | -652,632.00 |
| Dec 31, 2016 | -652,632.00 |
| Sep 30, 2016 | -657,234.00 |
| Sep 30, 2016 | -657,234.00 |